ShcA signalling is essential for tumour progression in mouse models of human breast cancer
Josie Ursini‐Siegel(McGill University), William J. Muller(McGill University Health Centre)
Cited by 159
Related Papers
Oncogenes and Tumor Suppressor Genes
|Cold Spring Harbor Perspectives in Biology|2010|504
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
|Nature Communications|2018|84
PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis
|Journal of Biological Chemistry|2009|78
Targeting fatty acid oxidation enhances response to HER2-targeted therapy
|Nature Communications|2024|50
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression
|Journal of Clinical Investigation|2023|36